טוען...
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
The aim was to determine whether losartan reduces cigarette smoke (CS)-induced airway inflammation and mucus hypersecretion in an in vitro model and a small clinical trial. Primary human bronchial epithelial cells (HBECs) were differentiated at the air–liquid interface (ALI) and exposed to CS. Expre...
שמור ב:
| הוצא לאור ב: | ERJ Open Res |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
European Respiratory Society
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7836504/ https://ncbi.nlm.nih.gov/pubmed/33532463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00394-2020 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|